Saulo Passos

Prof. Saulo Passos

Jundiai Medical School
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
LCLuiz Carlos Caires-Júnior
Luiz Carlos Caires-Júnior
EGErnesto Goulart
Ernesto Goulart
UMUirá Souto Melo
Uirá Souto Melo
BABruno Araujo
Bruno Araujo
LALucas Alvizi
Lucas Alvizi
MZMAYANA ZATZ
MAYANA ZATZ
Congenital Zika syndrome (CZS) causes early brain development impairment by affecting neural progenitor cells (NPCs). Here, we analyze NPCs from three pairs of dizygotic twins discordant for CZS. We compare by RNA-Seq the NPCs derived from CZS-affected and CZS-unaffected twins. Prior to Zika virus (ZIKV) infection the NPCs from CZS babies show a significantly different gene expression signature of mTOR and Wnt pathway regulators, key to a neurodevelopmental program. Following ZIKV in vitro infection, cells from affected individuals have significantly higher ZIKV replication and reduced cell growth. Whole-exome analysis in 18 affected CZS babies as compared to 5 unaffected twins and 609 controls excludes a monogenic model to explain resistance or increased susceptibility to CZS development. Overall, our results indicate that CZS is not a stochastic event and depends on NPC intrinsic susceptibility, possibly related to oligogenic and/or epigenetic mechanisms.

27 February 2014 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
CVChristian Julián Villabona-Arenas
Christian Julián Villabona-Arenas
JOJessica Luana de Oliveira
Jessica Luana de Oliveira
CCCarla de Sousa Capra
Carla de Sousa Capra
KBKarime Balarini
Karime Balarini
MLMauricio Loureiro
Mauricio Loureiro
PZPaolo Marinho de Andrade Zanotto
Paolo Marinho de Andrade Zanotto
FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo) 2010/19059-7FAPESP 2011/17071-2 and 2013/10382-8CNP

Stela Maria Tavolieri de OliveiraStela Maria Tavolieri de Oliveira
Stela Maria Tavolieri de Oliveira
EGEwerton Alexandre Galdeano
Ewerton Alexandre Galdeano
ETEvelynne Maria Gomes Galvão da Trindade
Evelynne Maria Gomes Galvão da Trindade
RFRafael Saad Fernandez
Rafael Saad Fernandez
Rogerio Leone BuchaimRogerio Leone Buchaim
Rogerio Leone Buchaim
Saulo PassosSaulo Passos
Saulo Passos
The aim of this study was to identify the epidemiological profiles of violence against children, victims, and their aggressors, and their correlations between socioeconomic and demographic factors analyzed before and during the COVID-19 pandemic. This was a cross-sectional, retrospective observational study based on a review of Individual Notification Forms from the Information System for Notifiable Diseases, including child victims of violence, under 18 years, assisted by a pediatric emergency service in Brazil, from 2016–2020. Data were stratified, then statistical analysis was performed using the two-proportion equality test and the Chi-square test, with p < 0.05 and a 95% confidence interval. A total of 609 notifications were analyzed and a prevalence of sexual violence (63.2%) was reported. The prevalent profile of victim was female (76.7%), aged between 2–9 years (38.1%) and 14–18 years (35.6%). The violence occurs in the victim’s home (58.9%). The prevalent profile of perpetrator was male (82.4%), young adolescent (59.2%), living as family (64%), mainly the parents (18.4%). No correlation was found between the classified socioeconomic and demographic variables and violence. There was an increase in notifications during the COVID-19 pandemic, compared to the same period in the previous year; self-harm was reported in 59.7% of physical violence in 2020. Prevalence of sexual violence was higher for females, aged between 2–9 and 14–18 years, victimized in their homes, by male offenders, living as family, mainly by their parents. No association was found between child violence and the socioeconomic and demographic.

18 June 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
AWAnnelies Wilder-Smith
Annelies Wilder-Smith
YWYinghui Wei
Yinghui Wei
TAThalia Velho Barreto de Araújo
Thalia Velho Barreto de Araújo
MVMaria VanKerkhove
Maria VanKerkhove
CMCelina Maria Turchi Martelli
Celina Maria Turchi Martelli
JAJackeline Alger
Jackeline Alger
Introduction Zika virus (ZIKV) infection during pregnancy is a known cause of microcephaly and other congenital and developmental anomalies. In the absence of a ZIKV vaccine or prophylactics, principal investigators (PIs) and international leaders in ZIKV research have formed the ZIKV Individual Participant Data (IPD) Consortium to identify, collect and synthesise IPD from longitudinal studies of pregnant women that measure ZIKV infection during pregnancy and fetal, infant or child outcomes. Methods and analysis We will identify eligible studies through the ZIKV IPD Consortium membership and a systematic review and invite study PIs to participate in the IPD meta-analysis (IPD-MA). We will use the combined dataset to estimate the relative and absolute risk of congenital Zika syndrome (CZS), including microcephaly and late symptomatic congenital infections; identify and explore sources of heterogeneity in those estimates and develop and validate a risk prediction model to identify the pregnancies at the highest risk of CZS or adverse developmental outcomes. The variable accuracy of diagnostic assays and differences in exposure and outcome definitions means that included studies will have a higher level of systematic variability, a component of measurement error, than an IPD-MA of studies of an established pathogen. We will use expert testimony, existing internal and external diagnostic accuracy validation studies and laboratory external quality assessments to inform the distribution of measurement error in our models. We will apply both Bayesian and frequentist methods to directly account for these and other sources of uncertainty. Ethics and dissemination The IPD-MA was deemed exempt from ethical review. We will convene a group of patient advocates to evaluate the ethical implications and utility of the risk stratification tool. Findings from these analyses will be shared via national and international conferences and through publication in open access, peer-reviewed journals. Trial registration number PROSPERO International prospective register of systematic reviews (CRD42017068915).

1 August 1994 in Epidemiology and Infection
Verified
Journal Article
Closed access
PDF file
RARaymundo Soares Azevedo
Raymundo Soares Azevedo
ASA. S. B. Silveira
A. S. B. Silveira
DND. J. Nokes
D. J. Nokes
HYH. M. Yang
H. M. Yang
Saulo PassosSaulo Passos
Saulo Passos
EMEduardo Massad
Eduardo Massad
SUMMARY A rubella serological survey of 476 individuals selected by cluster sampling technique from Caieiras, a small town located in the outskirts of São Paulo city, southeastern Brazil, was carried out over the period November 1990–January 1991. The aim of the study was to characterize rubella epidemiology in a representative non-immunized community in south east Brazil. The survey comprised a seroprevalence study, stratified by age (0–40 years) and a seroconversion study of rubella vaccine in non-infected children below 2 years of age. Mathematical techniques were applied to resultant data sets to determine the age dependent rates of decay in the proportion of individuals with maternally derived antibodies, vaccine seroconversion, and infection of susceptibles, termed the force of infection, and to estimate the average age at first infection.

1 December 2008 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
RPRogério Pecchini
Rogério Pecchini
EBEitan N. Berezin
Eitan N. Berezin
MFMaria C. Calahani Felício
Maria C. Calahani Felício
Saulo PassosSaulo Passos
Saulo Passos
MSMaria Cândido O. de Souza
Maria Cândido O. de Souza
EDEdison Durigon
Edison Durigon
The purpose of this study was to identify the rate of infections due to RSV and other viruses in children. In addition we have analyzed demographic data and clinical characteristics of the RSV-positive patients comparing with patients infected by other respiratory viruses. We also described the seasonality of the RSV occurrence in a hospital in São Paulo. Children below 5 years old admitted in Santa Casa de São Paulo Hospital between February 2005 and September 2006 due to acute respiratory infections (ARI) were included. A nasopharyngeal specimens were obtained with sterile No. 5 French feeding catheters as soon as possible (usually within 24 h). Specimens were kept refrigerated at 4 degrees C and transported to Adolfo Lutz Institute, where the indirect immunofluorescent assay was performed. Virus identified by these assay included RSV, Adenovirus, Influenza A and B virus and Parainfluenza 1, 2, and 3. Clinical data from each group was compared. Four hundred and fifty five cases were included in the study, with 30% positive for some type of virus. Viruses that were identified included Respiratory Syncytial Virus (73.03%), Influenza (8.42%), Parainfluenza (8.42%) and Adenovirus (3.37%). We divided the subjects in 3 groups: Group 1 RSV-Positive, Group 2 Other Positive Viruses and Group 3 Negative for Respiratory Virus. Mean age (months) was of 7.5 for RSV-positive children, 7.6 for other viruses, and 8 for negative for respiratory virus. The RSV-Positive Group was significantly younger than the Group Negative for Respiratory Virus (p<0.05). Signs of UAI were more present in the Positive RSV Group (p<0.05). General mortality was of 2.41%. There was a higher incidence of RSV between the months of March and August in the two years of the study. Our study indicates RSV as the most prevalent viral agent in children admitted due to (ARI), especially in infants below 3 months old. We have also found that infections due to RSV can occur in months others than the classic seasonal period.